Due to health issues, this site is no longer maintained and will be shut down shortly. |
Mesoblast Ltd is engaged in the development of biologic products for the broad field of regenerative medicine. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage adult stem cells. This is an ADR of a company whose stock trades outside of the U.S. as the symbol AT:MSB.
$3.17 +0.08 (2.59%)
As of 03/27/2023 12:45:00 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.